PDG62 THE CONTINUUM OF INTERNATIONAL REFERENCE PRICING USE IN LATIN AMERICA: A QUALITATIVE ANALYSIS.

As new governments embark on ambitious healthcare reform in Latin America, international reference pricing (IRP) continues to be explored as a policy tool to control pharmaceutical prices. This analysis sought to characterize the degree of formality of IRP application in key Latin America countries, as well as the specific settings in which it is used, to understand whether core archetypes are emerging. Albeit case-dependent, Brazil also employs IRP informally to facilitate negotiations for single-source drugs, ineligible for public sector tendering. [Extracted from the article]